New transcription factors and their role in diabetes and therapy /
This book contains contributions from some of the most eminent experts in the fields of genetics, biochemistry, and pathophysiology of diabetes. Through specific examples, with broad applications, this book provides a comprehensive look at how transcription factors may underline the pathogenetic mec...
| Άλλοι συγγραφείς: | |
|---|---|
| Μορφή: | Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Amsterdam ; Boston :
Elsevier,
2006.
|
| Έκδοση: | 1st ed. |
| Σειρά: | Advances in molecular and cellular endocrinology ;
v. 5. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. PPARs as therapeutic targets for treating diabetes and insulin resistance
- 2. Genetic regulators of human obesity and diabetes
- 3. NF-kb, insulin resistance and the actions of salicylates
- 4. Wnt signaling and C/EBPs role in adipogenesis
- 5. Regulation of hepatic gluconeogenesis C/EPBs
- 6. Forkhead proteins and regulation of hepatic gene expression
- 7. Control of mitochondrial biogenesis through PGC-1
- 8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications
- 9. FOXC2 controls resistance to obesity and Type II diabetes
- 10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
- 11. GATA proteins as molecular gatekeeprs of the adipocyte
- 12. Diabetes regulation of gene expression by CREB
- 13. Molecular etiologies of MODY and other early-onset forms of diabetes
- 14. Liver X receptors as potential drug targets for Diabetes and its disorders
- 15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis
- 16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys
- 17. PPARgamma and metabolism: Insights from the study of human genetic variants.
- Transcription factor genes in type 2 diabetes / by M.N. Weedon, A.T. Hattersley & T.M. Frayling
- PPAR[gamma], a key therapeutic target in the metabolic syndrome-unique insights derived from the study of human genetic variants / by C.S. Mitchell & M. Gurnell
- PPAR[delta]: emerging therapeutic potential of novel agonists in lipid and glucose homeostasis / by U. Dressel & G.E.O. Muscat
- Liver X receptors as potential drug targets for diabetes and its disorders / by K.R. Steffenson
- SREBP-lc regulation of nutrient homeostasis and lipid accumulation / by P. Ferré [and others]
- The adipocyte and adipose tissue as endocrine organs: impact on the insulin resistance phenotype / by R.R. Henry [and others]
- FOXC2 in the adipocyte / by S. Enerbäck
- Regulation of adipocyte differentiation and metabolism by Wnt signaling and C/EBP transcription factors / by I. Gerin, H.D. Cha & O.A. MacDougald
- GATA proteins as molecular gatekeepers of adipogenesis / by J. Tsai, Q. Tong & G.S. Hotamisligil
- Forkhead proteins and the regulation of hepatic gene expression / by A. Barthel, S. Herzig & D. Schmoll
- Disruption of CREB regulated of gene expression in diabetes / by J.E.B. Reusch, P.A. Watson & S. Pugazhenthi
- Regulation of PGC-1 in humans with insulin resistance and type 2 diabetes: functional implications / by J. Pihlajamäki & M.E. Patti
- Hepatic CCAAT/enhancer binding protein [beta] (C/EBP[beta]): engineer of diabetes, obesity, and inflammatory disease processes / by J.M. Schroeder-Gloeckler, S.M. Rahman & J.E. Friedman
- Insulin resistance, inflammation, and the IKK/I[kappa]B/NF-[kappa]B pathway by B.A. Bhatt & R.M. O'Doherty.
